Format

Send to

Choose Destination
Diabetes Obes Metab. 2018 May;20(5):1140-1147. doi: 10.1111/dom.13203. Epub 2018 Jan 25.

Injecting without pressing a button: An exploratory study of a shield-triggered injection mechanism.

Author information

1
Profil, Neuss, Germany.
2
Profil, Mainz, Germany.
3
Novo Nordisk A/S, Hillerød, Denmark.
4
Novo Nordisk A/S, Søborg, Denmark.

Abstract

AIMS:

To evaluate the injection success and user perception of a shield-triggered pen-injector mechanism.

METHODS:

The trial (ClinicalTrials.gov NCT02627287) was an exploratory, two-centre, one-visit, open-label, randomized controlled trial conducted in Germany in 150 injection-experienced individuals with type 1 or type 2 diabetes. Participants self-administered subcutaneous injections of a placebo solution using a prototype shield-triggered pen-injector, DV3316 (Novo Nordisk, Bagsvaerd, Denmark), and FlexPen (Novo Nordisk, Bagsvaerd, Denmark). Injection success was evaluated on a yes/no basis by the investigator. Participant confidence, leakage of fluid and pain were evaluated after each injection. Pain and device experience were assessed after completion of all injections with each pen-injector. Overall preference was assessed after completion of all injections with both pen-injectors.

RESULTS:

Injection success was high with both pen-injectors (97.0%, DV3316 vs 99.7%, FlexPen). Participant confidence in dose delivery was similar for the two devices (88% of injections with DV3316 vs 81% with FlexPen were scored as "extremely confident"). The median injection pain score on a visual analogue scale (0-100) was 3 with DV3316 vs 4 with FlexPen after each injection, and 4 with DV3316 vs 5 with FlexPen after all injections with each device. After all injections were completed, 55% of participants reported an overall preference for DV3316 vs 21% for FlexPen.

CONCLUSION:

This study demonstrates that injection-experienced individuals can achieve a high injection success rate with a shield-triggered pen-injector, with similar patient confidence and injection pain compared with FlexPen.

KEYWORDS:

FlexPen; confidence; pain; pen-injector; subcutaneous injections

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center